BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 26603132)

  • 1. Orbital implants in retinoblastoma patients: 23 years of experience and a review of the literature.
    Mourits DL; Moll AC; Bosscha MI; Tan HS; Hartong DT
    Acta Ophthalmol; 2016 Mar; 94(2):165-74. PubMed ID: 26603132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposure of orbital implants wrapped with polyester-urethane after enucleation for advanced retinoblastoma.
    Heimann H; Bechrakis NE; Zepeda LC; Coupland SE; Hellmich M; Foerster MH
    Ophthalmic Plast Reconstr Surg; 2005 Mar; 21(2):123-8. PubMed ID: 15778666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of orbital volumes in enucleated patients with unilateral retinoblastoma: hydroxyapatite implants versus silicone implants.
    Lyle CE; Wilson MW; Li CS; Kaste SC
    Ophthalmic Plast Reconstr Surg; 2007; 23(5):393-6. PubMed ID: 17881992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposure of primary orbital implants in postenucleation retinoblastoma patients.
    Lee V; Subak-Sharpe I; Hungerford JL; Davies NP; Logani S
    Ophthalmology; 2000 May; 107(5):940-5; discussion 946. PubMed ID: 10811087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Porous orbital implant after enucleation in retinoblastoma patients: indications and complications.
    Lang P; Kim JW; McGovern K; Reid MW; Subramanian K; Murphree AL; Berry JL
    Orbit; 2018 Dec; 37(6):438-443. PubMed ID: 29461921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of natural hydroxyapatite implants covered with Vicryl® mesh in a series of 704 enucleations].
    Ricaud X; Levy-Gabriel C; Lumbroso-Le Rouic L; Cassoux N; Esteve M; Plancher C; Asselain B; Desjardins L
    J Fr Ophtalmol; 2014 Feb; 37(2):99-106. PubMed ID: 24210936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure rate of hydroxyapatite orbital implants a 15-year experience of 802 cases.
    Yoon JS; Lew H; Kim SJ; Lee SY
    Ophthalmology; 2008 Mar; 115(3):566-572.e2. PubMed ID: 17854900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary orbital polymethylmethacrylate implant following primary enucleation for retinoblastoma: a study of 321 cases.
    Taneja S; Aldoais T; Kaliki S
    Orbit; 2021 Apr; 40(2):127-132. PubMed ID: 32252576
    [No Abstract]   [Full Text] [Related]  

  • 9. Anophthalmic Sockets in Retinoblastoma: A Single Center Experience.
    Jeyabal P; Sundar G
    Asia Pac J Ophthalmol (Phila); 2018; 7(5):307-311. PubMed ID: 30074308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cosmetic results of enucleation and/or external beam radiation therapy in 195 retinoblastoma survivors.
    Mourits DL; Hartong DT; Lissenberg-Witte BI; Bosscha MI; Tan HS; Moll AC
    Acta Ophthalmol; 2018 Sep; 96(6):631-640. PubMed ID: 29537141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porous orbital implants, wraps, and PEG placement in the pediatric population after enucleation.
    Wang JK; Liao SL; Lin LL; Kao SC; Tseng HS
    Am J Ophthalmol; 2007 Jul; 144(1):109-116. PubMed ID: 17499206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxyapatite orbital implant in children following enucleation: analysis of 531 sockets.
    Shah SU; Shields CL; Lally SE; Shields JA
    Ophthalmic Plast Reconstr Surg; 2015; 31(2):108-14. PubMed ID: 24896774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scleral wrap increases the long-term complication risk of bone-derived hydroxyapatite orbital implants.
    Toh T; Bevin TH; Molteno AC
    Clin Exp Ophthalmol; 2008 Nov; 36(8):756-61. PubMed ID: 19128381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric anophthalmic sockets and orbital implants: outcomes with polymer-coated implants.
    Kirzhner M; Shildkrot Y; Haik BG; Qaddoumi I; Rodriguez-Galindo C; Wilson MW
    Ophthalmology; 2013 Jun; 120(6):1300-4. PubMed ID: 23399376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The quasi-integrated porous polyethylene implant in pediatric patients enucleated for retinoblastoma.
    Marx DP; Vagefi MR; Bearden WH; Anderson RL; Yen MT
    Orbit; 2008; 27(6):403-6. PubMed ID: 19085293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of smooth surface tunnel porous polyethylene orbital implants (Medpor SST) in children with retinoblastoma.
    Choi YJ; Park C; Jin HC; Choung HK; Lee MJ; Kim N; Khwarg SI; Yu YS
    Br J Ophthalmol; 2013 Dec; 97(12):1530-3. PubMed ID: 24064935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of results of enucleations with orbital implant in children and adolescents].
    Hautz W; Grałek M; Karczmarewicz B; Kanigowska K; Klimczak-Slaczka D; Chipczyńska B
    Klin Oczna; 2006; 108(7-9):312-5. PubMed ID: 17290831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of cancer therapies on pediatric anophthalmic sockets.
    Shildkrot Y; Kirzhner M; Haik BG; Qaddoumi I; Rodriguez-Galindo C; Wilson MW
    Ophthalmology; 2011 Dec; 118(12):2480-6. PubMed ID: 21856015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of porous polyethylene implant exposure in patients with retinoblastoma following enucleation.
    Kim JH; Khwarg SI; Choung HK; Yu YS
    Ophthalmic Surg Lasers Imaging; 2004; 35(6):446-52. PubMed ID: 15580966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced magnetic resonance imaging of fibrovascular tissue ingrowth within synthetic hydroxyapatite orbital implants in children.
    Galluzzi P; De Francesco S; Giacalone G; Cerase A; Monti L; Vallone IM; Lazzeretti L; Venturi C; Hadjistilianou T
    Eur J Ophthalmol; 2011; 21(5):521-8. PubMed ID: 21279974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.